Immatics Appoints CFO
This article was originally published in Scrip
Immatics Biotechnologies GmbH., a company focused on cancer immunotherapy, has appointed Katina Dorton chief financial officer (CFO) – effective immediately. Dorton has over 20 years' experience in investment banking and has been senior strategic advisor to various companies in the life sciences, medical devices and healthcare sectors. She is former managing director investment banking, Morgan Stanley in New York and Frankfurt, Germany and was also managing director, life sciences at Needham & Co.